DRL
Company Details
Linkedin ID:
dr--reddys-laboratories
Website:
Employees number:
30,765
Number of followers:
1,669,184
NAICS:
3254
Industry Type:
Homepage:
drreddys.com
IP Addresses:
0
Company ID:
DR._2492461
Scan Status:
In-progress
Dr. Reddy's Laboratories Company CyberSecurity Posture
drreddys.com
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ
Dr. Reddy's Laboratories A.I CyberSecurity Scoring
DRL Risk Score (AI oriented)Between 750 and 799
DRL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
DRL Global Score (TPRM)XXXX
DRL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
DRL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
DRL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for DRL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Dr. Reddy's Laboratories in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Dr. Reddy's Laboratories in 2025.
Incident Types DRL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Dr. Reddy's Laboratories in 2025.
Incident History — DRL (X = Date, Y = Severity)
DRL cyber incidents detection timeline including parent company and subsidiaries
DRL Company Subsidiaries
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ
Loading...
DRL Similar Companies
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
Hyderabad Pharmaceutical Congress Committee
HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi
AUROBINDO PHARMA LTD
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active
Alkem Laboratories Ltd.
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient,
EMS is the leading pharmaceutical company in Brazil. Established since 45 years and with 100% national capital, the company has two industrial plants strategically placed in São Bernardo do Campo and Hortolândia, in the state of São Paulo. With a work based on daring, simplicity, excellence and res
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t
Takeda
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by list
MANKIND PHARMA LTD
Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,
The Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving ac
.png)
DRL CyberSecurity News
November 25, 2025 04:23 AM
New initiative aims to strengthen India's homegrown cyber resilience
Aimed at fostering homegrown resilience and viable career paths, Cyber Security Innovation Challenge (CSIC) 1.0 seeks to develop...
November 21, 2025 05:14 AM
Dentsu’s Merkle suffers data breach, sensitive information stolen
Dentsu confirms a data breach at Merkle's UK operations, with sensitive employee and limited client information stolen after suspicious...
November 12, 2025 08:00 AM
Dr. Reddy’s Laboratories Falls Victim to ₹2.16 Crore Cyber Fraud Through Fake Emails
Hackers impersonated vendor in email scam, diverting ₹2.16 crore payment from dr Reddy's lab.
November 11, 2025 08:00 AM
Dr. Reddy's Laboratories Thwarts Cyber Fraud Attempt, Confirms No Financial Loss
Dr Reddy's Laboratories successfully prevented a cyber fraud attempt involving vendor email impersonation. The hackers tried to redirect a...
November 10, 2025 08:00 AM
Bengaluru cyber fraud: Hackers target Dr Reddy’s Lab in scam attempt — How pharma company risked losing o
Cybersecurity News: Dr Reddy's Laboratories lost Rs 2.16 crore to fraudsters who infiltrated an email thread and rerouted a payment to a...
November 10, 2025 08:00 AM
Cyber Fraud: Dr. Reddy’s Laboratories Loses ₹2.16 Crore After Fraudsters Hack Email Communication
Dr. Reddy's Laboratories reportedly lost ₹2.16 crore in a major cyber fraud after scammers hacked into company email exchanges.
November 10, 2025 08:00 AM
Dr. Reddy's Laboratories Sees Significant Block Trade on NSE
A significant block trade of Dr Reddy's Laboratories shares occurred on the National Stock Exchange (NSE). The transaction involved 1068662...
November 09, 2025 05:59 PM
India cyber fraud: Dr Reddy’s loses ₹2.16 crore in email impersonation scam
Dr Reddy's Laboratories in India has lost ₹2.16 crore after cyber criminals allegedly hacked email exchanges with Group Pharmaceuticals and...
November 09, 2025 08:00 AM
Dr Reddy’s Labs loses Rs 2.16 crore in cyber fraud after hackers spoof executive email
In a major case of corporate cyber fraud, Dr. Reddy's Laboratories Ltd. has reportedly lost Rs 2.16 crore after hackers impersonated a...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
DRL CyberSecurity History Information
Official Website of Dr. Reddy's Laboratories
The official website of Dr. Reddy's Laboratories is http://www.drreddys.com.
Dr. Reddy's Laboratories’s AI-Generated Cybersecurity Score
According to Rankiteo, Dr. Reddy's Laboratories’s AI-generated cybersecurity score is 784, reflecting their Fair security posture.
How many security badges does Dr. Reddy's Laboratories’ have ?
According to Rankiteo, Dr. Reddy's Laboratories currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Dr. Reddy's Laboratories have SOC 2 Type 1 certification ?
According to Rankiteo, Dr. Reddy's Laboratories is not certified under SOC 2 Type 1.
Does Dr. Reddy's Laboratories have SOC 2 Type 2 certification ?
According to Rankiteo, Dr. Reddy's Laboratories does not hold a SOC 2 Type 2 certification.
Does Dr. Reddy's Laboratories comply with GDPR ?
According to Rankiteo, Dr. Reddy's Laboratories is not listed as GDPR compliant.
Does Dr. Reddy's Laboratories have PCI DSS certification ?
According to Rankiteo, Dr. Reddy's Laboratories does not currently maintain PCI DSS compliance.
Does Dr. Reddy's Laboratories comply with HIPAA ?
According to Rankiteo, Dr. Reddy's Laboratories is not compliant with HIPAA regulations.
Does Dr. Reddy's Laboratories have ISO 27001 certification ?
According to Rankiteo,Dr. Reddy's Laboratories is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Dr. Reddy's Laboratories
Dr. Reddy's Laboratories operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Dr. Reddy's Laboratories
Dr. Reddy's Laboratories employs approximately 30,765 people worldwide.
Subsidiaries Owned by Dr. Reddy's Laboratories
Dr. Reddy's Laboratories presently has no subsidiaries across any sectors.
Dr. Reddy's Laboratories’s LinkedIn Followers
Dr. Reddy's Laboratories’s official LinkedIn profile has approximately 1,669,184 followers.
NAICS Classification of Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Dr. Reddy's Laboratories’s Presence on Crunchbase
No, Dr. Reddy's Laboratories does not have a profile on Crunchbase.
Dr. Reddy's Laboratories’s Presence on LinkedIn
Yes, Dr. Reddy's Laboratories maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/dr--reddys-laboratories.
Cybersecurity Incidents Involving Dr. Reddy's Laboratories
As of December 11, 2025, Rankiteo reports that Dr. Reddy's Laboratories has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Dr. Reddy's Laboratories has an estimated 5,413 peer or competitor companies worldwide.
Dr. Reddy's Laboratories CyberSecurity History Information
How many cyber incidents has Dr. Reddy's Laboratories faced ?
Total Incidents: According to Rankiteo, Dr. Reddy's Laboratories has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Dr. Reddy's Laboratories ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=dr--reddys-laboratories' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
